Waleed H. Hassanein, President & CEO at TransMedics Group, Inc. (TMDX), sold 14,075 shares at $143.65 ($2.0M) on 2024-06-14, disclosed to the SEC on 2024-06-17.
Scheduled sale ($2.0M) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $140.42 | 1,614 | $227K | 11.4% |
| 2 | $140.42 | 1,614 | $227K | 11.4% |
| 3 | $141.62 | 3,836 | $543K | 27.3% |
| 4 | $141.62 | 3,836 | $543K | 27.3% |
| 5 | $142.68 | 2,675 | $382K | 19.1% |
| 6 | $143.65 | 400 |
| $57K |
| 2.9% |
| 7 | $144.52 | 100 | $14K | 0.7% |
| Total | $141.62 avg | 14,075 | $2.0M | 100% |
| Filing → |
| TMDX | SELL | 2024-10-17 | $2.1M | — | Filing → |
| TMDX | SELL | 2024-09-17 | $2.6M | — | Filing → |
| TMDX | SELL | 2024-08-23 | $7.8M | — | Filing → |